| 151 |
17447416 | Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. | 2006 |
1 |
| 152 |
20104716 | [Diagnosis and therapy of idiopathic Parkinson's disease]. | 2006 May 15 |
1 |
| 153 |
15573406 | Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition. | 2005 Jan 1-15 |
1 |
| 154 |
15621213 | Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. | 2005 Feb |
2 |
| 155 |
15663351 | Rasagiline. | 2005 |
2 |
| 156 |
15710852 | A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. | 2005 Feb |
1 |
| 157 |
15850677 | Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. | 2005 Apr |
1 |
| 158 |
16007239 | Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease? | 2005 Summer |
2 |
| 159 |
16027398 | Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease. | 2005 Aug |
3 |
| 160 |
16110345 | Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline. | 2005 Jun |
2 |
| 161 |
16156677 | Alternatives to levodopa in the initial treatment of early Parkinson's disease. | 2005 |
1 |
| 162 |
16197359 | Rasagiline in the pharmacotherapy of Parkinson's disease--a review. | 2005 Oct |
1 |
| 163 |
16204711 | In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET. | 2005 Oct |
7 |
| 164 |
16274338 | Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors. | 2005 Nov |
1 |
| 165 |
16366596 | Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis. | 2005 Dec 29 |
5 |
| 166 |
14696044 | Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease? | 2004 Jan |
1 |
| 167 |
15027867 | Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. | 2004 Mar 25 |
4 |
| 168 |
15147504 | Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo. | 2004 Jun |
2 |
| 169 |
15300656 | Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients. | 2004 Aug |
1 |
| 170 |
15628826 | Tolerability, safety, pharmacodynamics, and pharmacokinetics of rasagiline: a potent, selective, and irreversible monoamine oxidase type B inhibitor. | 2004 Oct |
3 |
| 171 |
14555244 | The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline. | 2003 Oct 15 |
1 |
| 172 |
19810877 | Rasagiline: an anti-Parkinson drug with neuroprotective activity. | 2003 Nov |
1 |
| 173 |
12044957 | Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline. | 2002 Apr 30 |
1 |
| 174 |
12090555 | Rasagiline. Teva Pharmaceutical. | 2002 May |
1 |
| 175 |
12470183 | A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study. | 2002 Dec |
1 |
| 176 |
12504917 | Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours. | 2002 Dec |
1 |
| 177 |
11575866 | Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa. | 2000 Nov-Dec |
1 |
| 178 |
9564630 | (R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B. | 1998 |
1 |
| 179 |
2420928 | Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl. | 1986 May |
1 |